Global Antinuclear Antibody TestMarket to Growby CAGR of ~13% During 2022 – 2031on the Back of Rising Prevalence of Autoimmune Diseases


Research Nester published a report titled Antinuclear Antibody TestMarket: Global Demand Analysis & Opportunity Outlook 2031which delivers a detailed overview of the global antinuclear antibody test marketin terms of market segmentation by product, disease, technology, end-user, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, and supply and demand risk, along with a detailed discussion of current and future market trends that are associated with the growth of the market.

The global antinuclear antibody test market is projected to grow at a CAGR of ~13% by attaining a noteworthy revenue during the forecast period, i.e., 2022 – 2031. Factors such as, increasing awareness regarding ANA tests and the growing prevalence of autoimmune diseases worldwide are projected to propel the growth of the market over the forecast period.Based on a report published by World Health Organization (WHO), it was stated in 2017, 9 million people were suffering from type 1 diabetes.

Additionally, by technology, the global antinuclear antibody test market is segmented into immunofluorescence, multiplex assay, and ELISA. Out of these sub-segments, the ELISA segment is anticipated to acquire a notable share in the market during the forecast period. ELISA is the shortened form for enzyme-linked immunoassay. The growth of the segment is attributed to its higher utilization in the examination of antibodies in the blood. Furthermore, it is also utilized to monitor the level of therapeutic drugs.

Furthermore, the global antinuclear antibody test market, by region, is bifurcated into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. Out of these regions, the market inthe North America region is projected to grow at a noteworthy pace during the forecast period. The growth of the market in the region is attributed to the growing geriatric population and rising cases of autoimmune diseases. According to the report published by American Autoimmune Related Diseases Association (AARDA), it was found that more than 100 types of autoimmune diseases are circulating in the region, meanwhile, 50 million Americans have some sort of autoimmune disease.

The research is global in nature and covers a detailed analysis of the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of the Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook, etc. have also been covered and displayed in the research report.

Rising Cases of Diabetes Globally to Foster the Growth of the Market

A report by World Health Organization (WHO) stated that 422 million people of the global population have diabetes while in 2019, 1.5 million people lost their lives due to diabetes.

Diabetes is referred to as a metabolism disorder that occurs when the blood sugar gets too high or too low. The increased amount of sugar or glucose in the blood can be the major factor to cause health problems, such as, nerve damage, kidney diseases, and heart and eye problems. It requires a scheduled check-up and treatment. Therefore, such factors are anticipated to propel the growth of the market.

However, the lack of skilled medicalprofessionals and errors during the diagnosis procedure isexpected to operate as a key restraint to the growth of the globalantinuclear antibody test market over the forecast period.

This report also provides the existing competitive scenario of some of the key players in the global antinuclear antibody test market which includes company profiling ofF. Hoffmann-La Roche Ltd, ERBA Diagnostics, Inc., Zeus Scientific Inc., Trinity Biotech plc, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Immuno Concepts Inc, Euroimmun Medizinische Labordiagnostika AG, Antibodies Incorporated, and Becton, Dickinson and Company. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials, and recent news and developments. On the whole, the report depicts a detailed overview of the global antinuclear antibody test market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching for possibilities, and other stakeholders to align their market-centric strategies according to the ongoing and expected trends in the future.

Request Report Sample@

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates, and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided the right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decisions in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel


U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

Leave a Reply

Your email address will not be published. Required fields are marked *